Andreas Agathangelidis, PhD, is a molecular geneticist holding the position of Assistant Professor at the Department of Biology at the National and Kapodistrian University of Athens since 2021. He also holds the position of Academic Research Partner at the Institute of Applied Biosciences at the Centre for Research and Technology Hellas.His specialization is in immunogenetic research, focusing on the study of mechanisms dictating the characteristics of the immune repertoire in leukemias and lymphomas. He has experience in lymphoma/leukemia immunogenetics, as well as transcriptomics and cell functional studies. During his PhD and post-doc studies, he coordinated/participated in many large, multi-institutional studies on CLL covering different aspects of the pathophysiology of this disease, from genetic drivers to immune signaling. Relevant to the proposed project, in a recent study from 2021, his in-depth immunogenetic analysis of almost 30,000 patients with CLL led to important scientific findings with therapeutic relevance, culminating in the identification and characterization of satellite stereotyped subsets in CLL. Of importance, the applicant was a fellow of the HFRI (H.F.R.I. Research Projects to support Postdoctoral Researchers, grant agreement no 336, project CLLon). Thus, has obtained valuable experience in the administration of projects. Furthermore, the implementation of the project led to 6 high-impact scientific publications, indicating its overall success. Dr Agathangelidis is a member of the Hellenic Society of Haematology, the European Haematology Association, the European Research Initiative on CLL, the IgCLL group and the Panhellenic Association of Bioscientists. He has published 74 peer-reviewed publications (Pubmed), with 4.145 citations and h-index = 30 (Google Scholar).
Maria Karypidou, M.Sc. is a biologist and currently a Ph.D. candidate at the Institute of Applied Biosciences, Centre for Research and Technology Hellas (INAB|CERTH). She holds a master's degree specializing in Translational Research in Biomedicine of the Department of Molecular Biology and Genetics of the Democritus University of Thrace. Since 2015, she has been employed as a Special Technical Scientist at INAB|CERTH, where she is responsible for quality management systems compliant with ISO 15189 at the Molecular Diagnostics Unit. In parallel, she plays a central role in bioinformatic data analysis, data integration and clinical datasets with a particular focus on next-generation sequencing data. She is actively involved in the development of bioinformatics tools including lineagespot, a computational framework for the detection and characterization of SARS-CoV-2 lineages in biological samples using NGS technologies. Her work emphasizes the extraction of biologically and clinically meaningful insights through robust data processing pipelines and integrative analytical approaches. Maria has extensive experience in the processing and manipulation of human tissues and cells, the application of molecular diagnostic protocols, and the implementation of advanced bioinformatic workflows. She routinely applies statistical and computational methods to associate molecular profiles with phenotypic and clinical data, contributing to translational and precision medicine research. She is an active member of the European Hematology Association, the European Research Initiative on CLL, and the Hellenic Society of Hematology.
A postdoctoral fellow will be hired for the purposes of the project. Requirements will include the following: (i) a scientific background in cancer (B cell malignancies in particular), (ii) experience in conducting NGS experiments (PCR amplification, preparation of libraries, library quality/quantity assessment, and sequening), (iii) cell functional studies. Furthermore, experience in the fields of project administration as well as management will be highly appreciated.
Konstantinos Pasentsis obtained his BSc in Physics, Physics Department, Faculty of Natural Sciences, Aristotle University of Thessaloniki, Greece in 1988. In 1994, he finished the school at the Technological Institute in Munich, Germany and became a professional Chemisch tecnischer Assistant. He worked as technical assistant from 1994-1996 in the Laboratory of Molecular Biology, Botanic Institute, Ludwig Maximilian University, Munich, Germany. From 1996-1998 in the Laboratory of Clinical Pharmacology, Clinic of Pathology, Ludwig Maximilian University, Munich, Germany. From 1999-2002 as research assistant in the Laboratory of Pharmaceutical Plant Biotechnology, Department of Pharmacy, Faculty of Health Sciences, Aristotle University of Thessaloniki. From 2002-present he is working as research assistant at the Institute of Applied Biosciences, Centre for Research and Technology, Thermi, Thessaloniki, Greece. He has long-stand expertise on -omics and next gereration sequencing techniques and approaches. He is actively involved into the educational processes of the INAB|CERTH.
Anastasia Iatrou is a PhD candidate at the Institute of Applied Biosciences (INAB) of the Centre for Research & Technology Hellas (CERTH). After graduating as a molecular biologist and geneticist, in 2019, from the Department of Molecular Biology and Genetics of the Democritus University of Thrace, she earned a master's degree in Translational Research in Biomedicine. Since 2018, she has participated in various research projects at INAB and she has gained sufficient expertise combining next-generation sequencing, biochemical assays, molecular techniques and structural biology. In more detail, she has valuable experience in laboratory methodologies, including cultures of primary cells and cell lines, signaling studies, DNA cloning, flowcytometry, cell sorting of cell populations, crystallography, Enzyme-linked Immunosorbent Assays (ELISA), as well as state-of-the-art NGS techniques (i.e. RNA-seq, immunogenetics). Since 2023, she has been awarded a scholarship for doctoral studies by the Hellenic Foundation for Research and Innovation. Her research focuses on the micorenvironmental interactions in B cell lymphomas, namely chronic lymphocytic leukemia (CLL), splenic marginal zone lymphoma (SMZL), as well as pre-malignant conditions, such as monoclonal B lymphocytosis (MBL) and, in particular, the structural and functional analysis of the clonotypic B cell receptor immunoglobulin.
Aikaterini Mallou, M.Sc is a Ph.D. candidate at the Institute of Applied Biosciences, Centre for Research and Technology Hellas (INAB|CERTH), under the supervision of Dr Agathangelidis. She earned her B.Sc. in Biochemistry and Biotechnology (2023) from the University of Thessaly and subsequently completed an MSc in Translational Research in Biomedicine at the Democritus University of Thrace (Department of Molecular Biology and Genetics). She has been a member of the INAB Immunogenetics research team since 2022, where she has developed hands-on expertise across a broad range of experimental methodologies, including next-generation sequencing workflows (targeted DNA sequencing, RNA sequencing, and whole-exome sequencing), flow cytometry and cell sorting, and primary cell and cell-line culture. Her Ph.D. research focuses on the mechanisms of B-cell affinity maturation in mature B-cell lymphomas, with particular emphasis on how these processes shape lymphoma ontogeny and influence disease evolution and progression. Through this work, she aims to advance understanding of the immunogenetic features that drive clinically relevant tumor behavior.